-
NeOnc Lands New Coverage and Roth Sees Potential 2026 Trial Catalyst
-
NeOnc Lands New Coverage and Roth Sees Potential 2026 Trial Catalyst
-
NeOnc Technologies prices $15M direct offering at $4.20 per share
-
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors


